A major new peer-reviewed study from Florida has found a significant difference in mortality outcomes between two major COVID-19 shots. Adults who received the Pfizer-BioNTech (BNT162b2) shot showed a higher risk of death from any cause over 12 months compared to those who received the Moderna (mRNA-1273) shot.
The study tracked nearly two million Florida adults who received their first dose of either the Pfizer or Moderna vaccine between December 2020 and August 2021. Researchers compared mortality outcomes over the following year, matching participants by age, sex, race, ethnicity, vaccination month, vaccination site type, and neighborhood.
A stark pattern emerged, showing a disparity most severe among patients 60 and older. The Pfizer cohort experienced 784 deaths per 100,000 compared to 562 among Moderna recipients, a 40% higher risk. The analysis also showed particularly alarming gaps in cardiovascular fatalities (up 57%) and COVID-19-related deaths (up 91%), while non-COVID mortality was also significantly elevated at 37% higher.
The Gateway Pundit spoke to Nicholas Hulscher—an Epidemiologist and Administrator at the McCullough Foundation—expanded on the study’s findings.
First, applying the study’s 40 percent higher all-cause mortality hazard to an assumed 150 million U.S. Pfizer recipients and a baseline annual mortality rate of 0.87 percent, he calculated 522,000 potential excess deaths.
“That’s a hypothetical extrapolation of over half a million excess deaths from Pfizer alone,” he explained.
Hulscher then offered a more conservative estimate using the study’s absolute mortality difference: 221 additional deaths per 100,000 Pfizer recipients. This calculation yielded “331,500 additional deaths—if what we saw in Florida holds nationwide.”
